Cargando…
Treatment of melanoma with selected inhibitors of signaling kinases effectively reduces proliferation and induces expression of cell cycle inhibitors
Cancer treatment often tends to involve direct targeting enzymes essential for the growth and proliferation of cancer cells. The aim of this study was the recognition of the possible role of selected protein kinases: PI3K, ERK1/2, and mTOR in cell proliferation and cell cycle in malignant melanoma....
Autores principales: | Ciołczyk-Wierzbicka, Dorota, Gil, Dorota, Laidler, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719123/ https://www.ncbi.nlm.nih.gov/pubmed/29214525 http://dx.doi.org/10.1007/s12032-017-1069-0 |
Ejemplares similares
-
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2019) -
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2019) -
The inhibition of invasion of human melanoma cells through N-cadherin knock-down
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2018) -
Integrin-linked kinase regulates cadherin switch in bladder cancer
por: Gil, Dorota, et al.
Publicado: (2016) -
Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells
por: Ciołczyk-Wierzbicka, Dorota, et al.
Publicado: (2023)